Siteman Cancer Center

When cancer is complex, where you go matters. Siteman Cancer Center at Barnes-Jewish Hospital and @washumedicine: 700+ physicians and researchers, one of the largest clinical trial programs, rated “Exceptional” by @theNCI. Redefining what it means to live with and beyond cancer.

Congratulations to Nicholas Fisher, MBA, of Siteman Cancer Center, on being named a new member of the @AACI_Cancer Finance & Investment Committee. bit.ly/3Wv3yQY

1,000 patients in just three years.

The Head and Neck Tumor Center at Siteman brings @washumedicine surgeons, medical oncologists and radiation oncologists, along with nurse navigators and support specialists, together as one team for patients with any type of head or neck tumor.

Rick Sparrow is among the latest patients treated at the center. “We wanted to go to Siteman,” he said. “And once I had the initial consultation here, I wouldn’t have gone anywhere else.”

Read his story: bit.ly/4za8Grm

@washumedicine physician-scientists at Siteman Cancer Center are developing a combination therapy for NRAS-mutated melanoma, a highly aggressive form of the disease that occurs in up to 25% of patients diagnosed with cutaneous melanoma.

The therapy pairs two commercially available drugs, T-VEC and binimetinib. In an early-phase study led by George Ansstas, MD, David Y. Chen, MD, PhD, and Naresha Saligrama, PhD, six patients achieved a complete response, compared to only two out of seven patients who responded when treated with T-VEC alone.

The findings are published in @jclinicalinvest.

Read the full story: bit.ly/4ikzb8d

Congratulations to @washumedicine’s Samuel Urrutia, MD, MS, at Siteman Cancer Center on winning a Shaji Kumar Hematology Research Award. His goal: bring whole-genome sequencing to leukemia patients in Latin America, replacing tests that cost $3,000+ and take 60 days with results in 10 days bit.ly/4sCdgN6